Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minghan Wang

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Chemical Biology & Drug Design|January 18, 2012
Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signalingJunming Yie, Wei Wang, Liying Deng, et al.
Journal of Neuroinflammation|July 10, 2025
Gut microbiota-derived indoleacetic acid attenuates neuroinflammation and neurodegeneration in glaucoma through ahr/rage pathwayNing Wang, Chengyang Sun, Yijie Yang, et al.
Chemical Biology & Drug Design|December 12, 2007
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitorClarence Hale, Murielle Véniant, Zhulun Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Chester C Yuan, David Chow, et al.
Assay and Drug Development Technologies|March 16, 2007
High capacity homogeneous non-radioactive cortisol detection assays for human 11beta-hydroxysteroid dehydrogenase type 1Violeta Yu, Yanyan Tudor, Clarence Hale, et al.
Journal of Medicinal Chemistry|February 3, 2007
2-(S)-phenethylaminothiazolones as potent, orally efficacious inhibitors of 11beta-hydroxysteriod dehydrogenase type 1David J St Jean, Chester Yuan, Eric A Bercot, et al.
Journal of Clinical Pharmacology|July 29, 2010
Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitorJohn P Gibbs, Maurice G Emery, Ian McCaffery, et al.
Journal of Medicinal Chemistry|December 4, 2013
Piperazine oxadiazole inhibitors of acetyl-CoA carboxylaseMatthew P Bourbeau, Aaron Siegmund, John G Allen, et al.
BMC Medicine|April 4, 2022
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive studyZhiyuan Chen, Wen Zheng, Qianhui Wu, et al.
FEBS Letters|December 9, 2008
FGF21 N- and C-termini play different roles in receptor interaction and activationJunming Yie, Randy Hecht, Jennifer Patel, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Chemical Biology & Drug Design|January 18, 2012
Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signalingJunming Yie, Wei Wang, Liying Deng, et al.
Journal of Neuroinflammation|July 10, 2025
Gut microbiota-derived indoleacetic acid attenuates neuroinflammation and neurodegeneration in glaucoma through ahr/rage pathwayNing Wang, Chengyang Sun, Yijie Yang, et al.
Chemical Biology & Drug Design|December 12, 2007
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitorClarence Hale, Murielle Véniant, Zhulun Wang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 DiabetesAiwen Li, Chester C Yuan, David Chow, et al.
Assay and Drug Development Technologies|March 16, 2007
High capacity homogeneous non-radioactive cortisol detection assays for human 11beta-hydroxysteroid dehydrogenase type 1Violeta Yu, Yanyan Tudor, Clarence Hale, et al.
Journal of Medicinal Chemistry|February 3, 2007
2-(S)-phenethylaminothiazolones as potent, orally efficacious inhibitors of 11beta-hydroxysteriod dehydrogenase type 1David J St Jean, Chester Yuan, Eric A Bercot, et al.
Journal of Clinical Pharmacology|July 29, 2010
Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitorJohn P Gibbs, Maurice G Emery, Ian McCaffery, et al.
Journal of Medicinal Chemistry|December 4, 2013
Piperazine oxadiazole inhibitors of acetyl-CoA carboxylaseMatthew P Bourbeau, Aaron Siegmund, John G Allen, et al.
BMC Medicine|April 4, 2022
Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive studyZhiyuan Chen, Wen Zheng, Qianhui Wu, et al.
FEBS Letters|December 9, 2008
FGF21 N- and C-termini play different roles in receptor interaction and activationJunming Yie, Randy Hecht, Jennifer Patel, et al.
Pageof 8